| 前收盘价格 | 0.270 |
| 收盘价格 | 0.265 |
| 成交量 | 385,000 |
| 平均成交量 (3个月) | 363,982 |
| 市值 | 207,134,144 |
| 市盈率 (P/E TTM) | 26.50 |
| 价格/销量 (P/S) | 2.57 |
| 股市价格/股市净资产 (P/B) | 1.54 |
| 52周波幅 |
| 营业毛利率 | 6.33% |
| 营业利益率 (TTM) | 13.78% |
| 稀释每股收益 (EPS TTM) | 0.010 |
| 季度收入增长率 (YOY) | -34.50% |
| 季度盈利增长率 (YOY) | -39.80% |
| 总债务/股东权益 (D/E MRQ) | 13.30% |
| 流动比率 (MRQ) | 7.11 |
| 营业现金流 (OCF TTM) | 9.82 M |
| 资产报酬率 (ROA TTM) | 4.93% |
| 股东权益报酬率 (ROE TTM) | 5.98% |
市场趋势
| 短期 | 中期 | ||
| 行业 | Packaged Foods (MY) | 混合的 | 看跌 |
| Packaged Foods (全球的) | 混合的 | 看跌 | |
| 股票 | SUNZEN | - | - |
AIStockmoo 评分
| 分析师共识 | 0.0 |
| 内部交易活动 | NA |
| 价格波动 | 4.5 |
| 技术平均移动指标 | 2.5 |
| 技术振荡指标 | 3.0 |
| 平均 | 2.50 |
|
Sunzen Group Bhd Formerly Sunzen Biotech Bhd is engaged in the business of research and development of biotechnology and manufacturing and marketing of animal health products. The company operates in the business segments of Manufacturing and trading animal health products; Trading and processing of crude palm oil and related products; Traditional Chinese medicines and herbal health foods and beverages and loan financing; and Loan Financing. It generates key revenue from the Traditional Chinese medicines and herbal health foods and beverages segment. Geographically, it operates into Malaysia, China, Singapore, and Others, out of which Malaysia generates maximum revenue. |
|
| 部门 | Consumer Defensive |
| 行业 | Packaged Foods |
| 投资方式 | Small Core |
| 内部持股比例 | 59.77% |
该时间范围内无数据。
该时间范围内无数据。
| 日期 | 类型 | 细节 |
|---|---|---|
| 11 Nov 2025 | 公告 | Additional Listing Announcement /Subdivision of Shares |
| 16 Oct 2025 | 公告 | Additional Listing Announcement /Subdivision of Shares |
| 10 Oct 2025 | 公告 | Additional Listing Announcement /Subdivision of Shares |
| 07 Oct 2025 | 公告 | PROVISION OF FINANCIAL ASSISTANCE |
| 03 Oct 2025 | 公告 | Notice of SBB by a Company Pursuant to Section 127 (16) of CA 2016 |
| 19 Sep 2025 | 公告 | Immediate Announcement on Shares Buy Back |
| 19 Sep 2025 | 公告 | Changes in Director's Interest (Section 219 of CA 2016) - MR TEO YEK MING |
| 19 Sep 2025 | 公告 | Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - MR TEO YEK MING |
| 19 Sep 2025 | 公告 | DEALINGS IN LISTED SECURITIES (CHAPTER 14 OF LISTING REQUIREMENTS) : Dealings Outside Closed Period |
| 12 Sep 2025 | 公告 | Notice of SBB by a Company Pursuant to Section 127 (16) of CA 2016 |
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合